Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Comparison of Utilities Consumption Between Different Modalities of In-Center Haemodialysis

View resource
HDx

Genetic variability in rosuvastatin metabolism explains rhabdomyolysis and consequent acute renal failure.

View resource
HDx

Heart rate-adjusted augmentation index reduces after switching low-flux dialyzers to medium cut-off dialyzers in maintenance hemodialysis patients.

View resource
HDx

LEVIL evaluates the impact of HDx on HR-QoL and symptoms, including durability-of-effect and variability.

View resource
HDx

Low-T3 syndrome: endemic in hemodialysis patients?.

View resource
HDx

Quantitative analysis of dialytic protein loss with medium cut-off and high-flux membranes.

View resource
HDx

Removal of middle size molecules: effects on the modifications of subgroups of white cell types.

View resource
HDx

Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort's study 

View resource
HDx

 Short-term treatment with medium cut-off dialyzers increases muscle mass  with preserved fat tissue in maintenance HD patients.

View resource
HDx

WCN24-1263 SYMPTOM IMPROVEMENT ENABLED BY THERANOVA DIALYZER IN HEMODIALYSIS PATIENTS: A BEFORE AND AFTER STUDY.

View resource
HDx

Immunomodulation Driven by Theranova Filter during a Single HD Session.

View resource
HDx

WCN24-1658 Effectiveness of Medium Cut-Off Dialyzers in Hemodialysis Patients: An Economic Analysis.

View resource